Your browser doesn't support javascript.
loading
JunB is a key regulator of multiple myeloma bone marrow angiogenesis.
Fan, Fengjuan; Malvestiti, Stefano; Vallet, Sonia; Lind, Judith; Garcia-Manteiga, Jose Manuel; Morelli, Eugenio; Jiang, Qinyue; Seckinger, Anja; Hose, Dirk; Goldschmidt, Hartmut; Stadlbauer, Andreas; Sun, Chunyan; Mei, Heng; Pecherstorfer, Martin; Bakiri, Latifa; Wagner, Erwin F; Tonon, Giovanni; Sattler, Martin; Hu, Yu; Tassone, Pierfrancesco; Jaeger, Dirk; Podar, Klaus.
Afiliação
  • Fan F; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Malvestiti S; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany.
  • Vallet S; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany.
  • Lind J; Department of Internal Medicine II, University Hospital Krems, Krems an der Donau, Austria.
  • Garcia-Manteiga JM; Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria.
  • Morelli E; Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria.
  • Jiang Q; Center for Translational Genomics and Bioinformatics, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Seckinger A; Department of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Catanzaro, Italy.
  • Hose D; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Goldschmidt H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Stadlbauer A; University Hospital Heidelberg, Heidelberg, Germany.
  • Sun C; Laboratory of Hematology and Immunology & Laboratory for Myeloma Research, Vrije Universiteit Brussel (VUB) Belgium, Brussels, Belgium.
  • Mei H; University Hospital Heidelberg, Heidelberg, Germany.
  • Pecherstorfer M; Laboratory of Hematology and Immunology & Laboratory for Myeloma Research, Vrije Universiteit Brussel (VUB) Belgium, Brussels, Belgium.
  • Bakiri L; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany.
  • Wagner EF; University Hospital Heidelberg, Heidelberg, Germany.
  • Tonon G; Department of Neurosurgery, Friedrich-Alexander University (FAU) Erlangen-Nürnberg, Erlangen, Germany.
  • Sattler M; Institute of Medical Radiology, University Hospital St. Pölten, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria.
  • Hu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Tassone P; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Jaeger D; Department of Internal Medicine II, University Hospital Krems, Krems an der Donau, Austria.
  • Podar K; Genes & Disease Group, Department of Dermatology, Medical University of Vienna (MUW), Vienna, Austria.
Leukemia ; 35(12): 3509-3525, 2021 12.
Article em En | MEDLINE | ID: mdl-34007044

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Medula Óssea / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Medula Óssea / Mieloma Múltiplo Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China